413 GEN-009, a personalized neoantigen vaccine, elicits robust immune responses in individuals with advanced or metastatic solid tumors

413 GEN-009, a personalized neoantigen vaccine, elicits robust immune responses in individuals with advanced or metastatic solid tumors

Bibliographic Details
Main Authors: Thomas Davis, Jessica Flechtner, Mara Shainheit, Devin Champagne, Gabriella Santone, Syukri Shukor, Ece Bicak, Samuel Tipps, Li Xue
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer
id doaj-549af87438a745b4be7db9983a2954c7
record_format Article
spelling doaj-549af87438a745b4be7db9983a2954c72020-12-11T10:01:55ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.0413413 GEN-009, a personalized neoantigen vaccine, elicits robust immune responses in individuals with advanced or metastatic solid tumorsThomas Davis0Jessica Flechtner1Mara Shainheit2Devin Champagne3Gabriella Santone4Syukri Shukor5Ece Bicak6Samuel Tipps7Li Xue87Genocea Biosciences, Centreville, MD, USAAff1 grid.475330.60000000405579162Genocea Biosciences, Inc Cambridge MA USA 7Genocea Biosciences, Centreville, MD, USAGenocea Biosciences, Cambridge, MA, USAGenocea Biosciences, Cambridge, MA, USAGenocea Biosciences, Cambridge, MA, USAGenocea Biosciences, Cambridge, MA, USAGenocea Biosciences, Cambridge, MA, USAGenocea Biosciences, Cambridge, MA, USA
collection DOAJ
language English
format Article
sources DOAJ
author Thomas Davis
Jessica Flechtner
Mara Shainheit
Devin Champagne
Gabriella Santone
Syukri Shukor
Ece Bicak
Samuel Tipps
Li Xue
spellingShingle Thomas Davis
Jessica Flechtner
Mara Shainheit
Devin Champagne
Gabriella Santone
Syukri Shukor
Ece Bicak
Samuel Tipps
Li Xue
413 GEN-009, a personalized neoantigen vaccine, elicits robust immune responses in individuals with advanced or metastatic solid tumors
Journal for ImmunoTherapy of Cancer
author_facet Thomas Davis
Jessica Flechtner
Mara Shainheit
Devin Champagne
Gabriella Santone
Syukri Shukor
Ece Bicak
Samuel Tipps
Li Xue
author_sort Thomas Davis
title 413 GEN-009, a personalized neoantigen vaccine, elicits robust immune responses in individuals with advanced or metastatic solid tumors
title_short 413 GEN-009, a personalized neoantigen vaccine, elicits robust immune responses in individuals with advanced or metastatic solid tumors
title_full 413 GEN-009, a personalized neoantigen vaccine, elicits robust immune responses in individuals with advanced or metastatic solid tumors
title_fullStr 413 GEN-009, a personalized neoantigen vaccine, elicits robust immune responses in individuals with advanced or metastatic solid tumors
title_full_unstemmed 413 GEN-009, a personalized neoantigen vaccine, elicits robust immune responses in individuals with advanced or metastatic solid tumors
title_sort 413 gen-009, a personalized neoantigen vaccine, elicits robust immune responses in individuals with advanced or metastatic solid tumors
publisher BMJ Publishing Group
series Journal for ImmunoTherapy of Cancer
issn 2051-1426
publishDate 2020-11-01
work_keys_str_mv AT thomasdavis 413gen009apersonalizedneoantigenvaccineelicitsrobustimmuneresponsesinindividualswithadvancedormetastaticsolidtumors
AT jessicaflechtner 413gen009apersonalizedneoantigenvaccineelicitsrobustimmuneresponsesinindividualswithadvancedormetastaticsolidtumors
AT marashainheit 413gen009apersonalizedneoantigenvaccineelicitsrobustimmuneresponsesinindividualswithadvancedormetastaticsolidtumors
AT devinchampagne 413gen009apersonalizedneoantigenvaccineelicitsrobustimmuneresponsesinindividualswithadvancedormetastaticsolidtumors
AT gabriellasantone 413gen009apersonalizedneoantigenvaccineelicitsrobustimmuneresponsesinindividualswithadvancedormetastaticsolidtumors
AT syukrishukor 413gen009apersonalizedneoantigenvaccineelicitsrobustimmuneresponsesinindividualswithadvancedormetastaticsolidtumors
AT ecebicak 413gen009apersonalizedneoantigenvaccineelicitsrobustimmuneresponsesinindividualswithadvancedormetastaticsolidtumors
AT samueltipps 413gen009apersonalizedneoantigenvaccineelicitsrobustimmuneresponsesinindividualswithadvancedormetastaticsolidtumors
AT lixue 413gen009apersonalizedneoantigenvaccineelicitsrobustimmuneresponsesinindividualswithadvancedormetastaticsolidtumors
_version_ 1724386559157862400

Similar Items